Rhinoscleroma overview

Rhinoscleroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Rhinoscleroma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Rhinoscleroma overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rhinoscleroma overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rhinoscleroma overview
CDC on Rhinoscleroma overview
Rhinoscleroma overview in the news
Blogs on Rhinoscleroma overview
Directions to Hospitals Treating Rhinoscleroma
Risk calculators and risk factors for Rhinoscleroma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Rhinoscleroma is a chronic granulomatous bacterial disease of the nose that can sometimes infect the upper respiratory tract. It most commonly affects the nasal cavity—the nose is involved in 95-100 per cent of cases—however, it can also affect the nasopharynx, larynx, trachea, and bronchi.

Epidemiology and Demographics

Slightly more females than males are affected and patients are usually 10 to 30 years of age. Rhinoscleroma is considered a tropical disease and is mostly endemic to Africa and Central America, less common in the United States.

Natural History, Complications and Prognosis

Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin. However, if left untreated the disease can lead to sepsis, hemorrhage or other chronic conditions that can be fatal.

Medical Therapy

Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin.